06/16/2026
Proud to celebrate a major milestone from Progentec Diagnostics.
Progentec's peer-reviewed research, published in Lupus Science & Medicine, introduces the Lupus Classification Risk Immune Index (L-CRI), a composite blood test score that can identify individuals at risk of developing lupus months to years before clinical diagnosis.
This breakthrough is paired with an OCAST Industry Innovation Grant to advance commercialization, a perfect example of Oklahoma innovation moving from early-stage science to real-world impact.
This is exactly why we do what we do: supporting founders building companies that strengthen Oklahoma's economy and improve lives.
Learn more about Progentec:
Progentec builds proactive care solutions for systemic lupus erythematosus, multiple sclerosis (MS), and other autoimmune diseases powered by proteomics and digital health